Assistant Professor, Psychiatry, Yale University School of Medicine

Psychiatry

Dr. Mohini Ranganathan, MD

Mohini Ranganathan works in the field of Psychiatry. She went to Calicut Medical College. Mohini Ranganathan is a published doctor. She published 30 publications, including: 'Human Laboratory Studies on Cannabinoids and Psychosis.'

Publications

Receptor Occupancy of the ÃŽÂº-Opioid Antagonist LY2456302 Measured with Positron Emission Tomography and the Novel Radiotracer 11C-LY2795050.
Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis.
Role of GABA Deficit in Sensitivity to the Psychotomimetic Effects of Amphetamine.
The early identification of psychosis: can lessons be learnt from cardiac stress testing?
GABA Deficit Enhances the Psychotomimetic Effects of ÃŽÂ”(9)-THC.
ÃŽÂ”(9)-THC Disrupts Gamma (ÃŽÂ³)-Band Neural Oscillations in Humans.
Testing differences in the activity of event-related potential sources: Important implications for clinical researchers.
The endocannabinoid system and schizophrenia: links to the underlying pathophysiology and to novel treatment approaches.
Effects of ÃŽÂ”(9)-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism.
In Vivo Evidence for ÃŽÂ²2 Nicotinic Acetylcholine Receptor Subunit Upregulation in Smokers as Compared with Nonsmokers with Schizophrenia.
Pilot study of Intravenous Nicotine Effects on Cognitive Performance in Schizophrenia.
Acute effects of THC on time perception in frequent and infrequent cannabis users.
Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the ÃŽÂº Opioid Agonist Salvinorin A in Humans.
Nicotine Fails to Attenuate Ketamine-Induced Cognitive Deficits and Negative and Positive Symptoms in Humans: Implications for Schizophrenia.
Cannabinoids, working memory, and schizophrenia.
Effects of nicotine on the neurophysiological and behavioral effects of ketamine in humans.
Treatment of hyperprolactinemia and gynecomastia with adjunctive aripiprazole in 2 men receiving long-acting injectable antipsychotics.
Glycine Transporter Inhibitor Attenuates the Psychotomimetic Effects of Ketamine in Healthy Males: Preliminary Evidence.
The safety of studies with intravenous ÃŽÂ”Ã¢ÂÂ¹-tetrahydrocannabinol in humans, with case histories.
[Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia].
Cannabis and psychosis/schizophrenia: human studies.
The effects of cannabinoids on serum cortisol and prolactin in humans.
Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans.
Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis.
The acute effects of cannabinoids on memory in humans: a review.
Evoked gamma band response in male adolescent subjects at high risk for alcoholism during a visual oddball task.
Suppression of early evoked gamma band response in male alcoholics during a visual oddball task.
Human Laboratory Studies on Cannabinoids and Psychosis.
Marijuana and Madness: Associations Between Cannabinoids and Psychosis.

Doctors Specialties

Psychiatry

Accepted Insurances

Education

SUNY Health Science Center at Brooklyn
Calicut Medical College

Helpful Reviews

Give Anonymous Review

Similar Doctors

	Dr. Mihai Caratas, MD This Doctor is OpenDoctor Recommended.
	Dr. Susan D. Kruger, MD This Doctor is OpenDoctor Recommended.
	Dr. Erika Jessen, MD
	Dr. Michael H. Ebert, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. David G. Greenfeld, MD This Doctor is OpenDoctor Recommended.
	Dr. Sudha Sreenivasan, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph J. Erdos Jr., MD This Doctor is OpenDoctor Recommended.
	Dr. Zoran A. Zimolo, MD
	Dr. Suzanne M. Carroll, MD
	Dr. Isabel S. Rathbone, MD This Doctor is OpenDoctor Recommended.
	Dr. Mehmet Sofuoglu, MD This Doctor is OpenDoctor Recommended. This doctor has more publications